Clinical Trial Update: Vaccination With Tetanus and KLH to Assess Immune Responses.

View source ↗

Summary

A terminated clinical trial evaluated immune responses to a vaccine consisting of tetanus toxoid and KLH in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• KLH (Keyhole Limpet Hemocyanin) vaccine (keyhole limpet hemocyanin)
• Tetanus toxoid vaccine (tetanus toxoid)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Cancer | Status: TERMINATED